Clinical trial
Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.
NCT01910038 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 8, 2013
- Completion date
- June 13, 2016
- Enrollment
- 20 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.